Glioblastoma multiforme is characterized in part by severe hypoxia associated with tumor necrosis. The cellular response to hypoxia can influence several properties of tumor cells associated with aggressive tumor growth, including metabolic adaptations and tumor cell migration and invasion. Here, we found that Delta Like Non-Canonical Notch Ligand 1 (DLK1) expression was elevated as compared with normal brain in a genetically engineered mouse model of glioma, and that DLK1 expression increased with tumor grade in human glioma samples. DLK1 expression was highest in hypoxic and perivascular tumor areas, and we found that hypoxia induced the release and nuclear translocation of an intracellular fragment of DLK1 in murine glioma as well as in human glioma cultures. Release of the intracellular fragment was dependent on ADAM17 and Hypoxia-inducible Factor 1alpha and 2alpha (HIF-1alpha/HIF-2alpha), as ADAM17 inhibitors and HIF1A/HIF2A siRNA blocked DLK1 cleavage. Expression of a cleavable form of DLK1 amplified several hypoxia-induced traits of glioma cells such as colony formation, stem cell marker gene expression, a PI3K-pathway-mediated metabolic shift, and enhanced invasiveness. Effects of DLK1 were dependent on DLK1-cleavage by ADAM17, as expression of non-cleavable DLK1 could not replicate the DLK1-induced hypoxic phenotype. Finally, forced expression of DLK1 resulted in more invasive tumor growth in a PDGFB-induced glioma mouse model without affecting overall survival. Together, our findings suggest a previously undescribed role for DLK1 as an intracellular signaling molecule.
Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma / E.S. Grassi, V. Pantazopoulou, A. Pietras. - In: ONCOGENE. - ISSN 0950-9232. - 39:20(2020), pp. 4028-4044.
|Titolo:||Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma|
GRASSI, ELISA STELLARIA (Primo)
|Parole Chiave:||stem-cellls; tumor; interacts; PREF-1; AKT; HIF-2-alpha; inhibition; activation; expression; phenotype|
|Settore Scientifico Disciplinare:||Settore MED/06 - Oncologia Medica|
Settore BIO/13 - Biologia Applicata
|Data di pubblicazione:||2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1038/s41388-020-1273-9|
|Appare nelle tipologie:||01 - Articolo su periodico|